[Issuer Free Writing Prospectus Registration Statement No. 333-230768 (Supplementing Preliminary Prospectus Supplement On April 10, 2019, at certain investor presentations, a representative of the Company indicated that there was a 60-70% probability that the Company may engage in an acquisition of a]
[Issuer Free Writing Prospectus Registration Statement No. 333-230768 (Supplementing Preliminary Prospectus Supplement On April 10, 2019, at certain investor presentations, a representative of the Company indicated that there was a 60-70% probability that the Company may engage in an acquisition of a]
[Table of Contents SEMILEDS CORPORATION FORM 10-Q for the Quarter Ended February 28, 2018 Page No. Part I. Financial Information Item 1. Financial Statements 1 Unaudited Condensed Consolidated Balance Sheets as of February 28, 2019 and August 31, 2018 1 Unaudited Condensed Consolidated Statements of ]
[Issuer Free Writing Prospectus Registration Statement No. 333-230768 (Supplementing Preliminary Prospectus Supplement On April 10, 2019, at certain investor presentations, a representative of the Company indicated that there was a 60-70% probability that the Company may engage in an acquisition of a]
[TABLE OF C INTRODUCTION 1 1 PART I. 2 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS 2 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 2 ITEM 3. KEY INFORMATION 2 ITEM 4. INFORMATION ON THE COMPANY 40 ITEM 4A UNRESOLVED STAFF COMMENTS 70 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROS]
[Table of Contents SEMILEDS CORPORATION FORM 10-Q for the Quarter Ended February 28, 2018 Page No. Part I. Financial Information Item 1. Financial Statements 1 Unaudited Condensed Consolidated Balance Sheets as of February 28, 2019 and August 31, 2018 1 Unaudited Condensed Consolidated Statements of ]
[Issuer Free Writing Prospectus Registration Statement No. 333-230768 (Supplementing Preliminary Prospectus Supplement On April 10, 2019, at certain investor presentations, a representative of the Company indicated that there was a 60-70% probability that the Company may engage in an acquisition of a]
[TABLE OF C INTRODUCTION 1 1 PART I. 2 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS 2 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 2 ITEM 3. KEY INFORMATION 2 ITEM 4. INFORMATION ON THE COMPANY 40 ITEM 4A UNRESOLVED STAFF COMMENTS 70 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROS]
[This Form 6-K consists of: DATE OF MEETING OF THE BOARD OF DIRECTORS Board Company The board of directors (the “ By Order of the Board Huaneng Power International, Inc. Huang Chaoquan Company Secretary As at the date of this announcement, the Directors of the Company are: (Executive Director) Shu Yi]
[PROSPECTUS SUPPLEMENT (To Prospectus dated April 10, 2019) File No. 333-230686 CHINA JO-JO DRUGSTORES, INC. 4,000,008 Shares of Common Stock Our common stock trades on the Nasdaq Capital Market under the symbol “CJJD.” The last reported sale price of our common stock on the Nasdaq Capital Market on ]
